Sanofi pledges to keep price hikes below healthcare inflation rate: 4 things to know

(By Mackenzie Bean for Becker’s Hospital Review)

Paris-based Sanofi is the latest drugmaker vowing to limit U.S. drug price hikes, reports Financial Times.

Here are four things to know. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or


Leave a Reply